Latest Capital Raise News

Page 12 of 619
CZR Resources (ASX:CZR) has launched a recommended all-scrip takeover bid for Zuleika Gold (ASX:ZAG), valuing the company at $44.8 million and offering a significant premium to Zuleika shareholders.
Maxwell Dee
Maxwell Dee
26 June 2026
Ioneer Ltd has been conditionally awarded a long-term land lease by the U.S. Army to establish a critical boron processing facility at the Tooele Army Depot in Utah, marking a significant step in securing domestic defense supply chains.
Maxwell Dee
Maxwell Dee
26 June 2026
Pengana Capital Group has successfully closed the $267 million initial public offering for its AI Private Opportunities Trust, marking a significant expansion in its fund management portfolio. The new trust is set to begin trading on the ASX on 2 July 2026.
Claire Turing
Claire Turing
25 June 2026
TruScreen Group has completed a substantially oversubscribed NZ$2.9 million rights issue, boosting total capital raised to over NZ$4 million. The funds are set to support the company’s global expansion in cervical screening technology.
Ada Torres
Ada Torres
25 June 2026
Pacific Edge reported a $35.8 million loss in FY26 amid a 47% revenue drop following Medicare coverage loss, but a draft Medicare policy and $36.1 million capital raise set the stage for recovery.
Ada Torres
Ada Torres
25 June 2026
Control Bionics has locked in $9.5 million through a discounted share placement, complemented by a $0.5 million Share Purchase Plan, to back its commercial growth and technology development.
Ada Torres
Ada Torres
25 June 2026
Flagship Minerals has agreed to sell its RK Lithium Project in Thailand for US$4 million, accelerating its strategic pivot towards gold and copper assets in Chile and Canada.
Maxwell Dee
Maxwell Dee
25 June 2026
Memphasys has rapidly established a foothold in the UK IVF market, securing four active commercial trials and initial orders for its Felix™ sperm selection system within weeks of launch. This momentum aligns with its global expansion strategy targeting major fertility markets.
Ada Torres
Ada Torres
25 June 2026
Imagion Biosystems has raised $3.75 million to fund the start of its Phase 1b/2 clinical trial for the MagSense HER2 imaging agent in the US, following FDA clearance. The capital raising involves a two-tranche share placement with free attaching options, led by CPS Capital.
Ada Torres
Ada Torres
25 June 2026
Kingston Resources launches a $8.47 million rights issue at a 12.5% discount, backed by a $4.4 million placement, to finance a major drilling campaign and plant expansion at Mineral Hill following the closure of its Pearse South open pit.
Maxwell Dee
Maxwell Dee
25 June 2026
Omega Oil & Gas has secured full funding for its 2026/27 appraisal campaign targeting the Taroom Trough, positioning the company to advance one of Australia’s most promising unconventional oil and gas plays.
Maxwell Dee
Maxwell Dee
25 June 2026
International Graphite Limited has inked a non-binding deal with Wogen Pacific to supply micronised graphite and feedstock for its Collie facility, targeting Asia-Pacific markets with an initial three-year term.
Maxwell Dee
Maxwell Dee
25 June 2026